CALM1 and prostate carcinoma: Further validation using the HPA databases revealed that the protein expression of CALM1 increases in breast cancer, liver cancer, and pancreatic cancer, but decreases in colorectal cancer, prostate cancer, and lung cancer, compared with that in normal tissues.